Long term dual antiplatelet drug therapy indicated

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47